You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.
You’re reading the web edition of STAT’s ADA in 30 Seconds
Elizabeth Cooney/STAT
You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter, from the American Diabetes Association’s annual conference. Sign up here
Welcome back! The American Diabetes Association annual conference is in full swing with news about old and new approaches to treating diabetes.
Buckle in for a day 2 recap.
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Once-daily GLP-1/GIP dual agonist lowers HbA1c, weight in type 1 diabetes
Retatrutide benefits in obesity, type 2 diabetes ‘quite staggering’
Next-generation automated insulin delivery algorithm raises time in range in diabetes
The American Diabetes Association's Innovation Fund Invests in UpDoc to Accelerate the Future of AI-Driven Chronic Disease Management and Prevention
CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA
AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change
Treating Obesity
